Author: Maddocks, O.D.K.; Athineos, D.; Cheung, E.C.; Lee, P.; Zhang, T.; van den Broek, N.J.F.; Mackay, G.M.; Labuschagne, C.F.; Gay, D.; Kruiswijk, F.; Blagih, J.; Vincent, D.F.; Campbell, K.J.; Ceteci, F.; Sansom, O.J.; Blyth, K.; Vousden, K.H.
Description: The non-essential amino acids serine and glycine are used in multiple anabolic processes that support cancer cell growth and proliferation. While some cancer cells upregulate de novo serine synthesis, many others rely on exogenous serine for optimal growth. Restriction of dietary serine and glycine can reduce tumor growth in xenograft and allograft models. Here we show that this observation translates into more clinically relevant autochthonous tumors in genetically engineered mouse models of intestinal cancer (driven by Apc inactivation) or lymphoma (driven by Myc activation). The increased survival following dietary restriction of serine and glycine in these models was further improved by antagonizing the anti-oxidant response. Disruption of mitochondrial oxidative phosphorylation (using biguanides) led to a complex response that could improve or impede the anti-tumor effect of serine and glycine starvation. Notably, Kras-driven mouse models of pancreatic and intestinal cancers were less responsive to depletion of serine and glycine, reflecting an ability of activated Kras to increase the expression of enzymes that are part of the serine synthesis pathway and thus promote de novo serine synthesis.
Subject headings: Tumor; Serine; Glycine; Amino acids; Cancer; Diet; Mitochondria
Publication year: 2017
Journal or book title: Nature
Volume: 544
Issue: 7650
Pages: 372-376
Find the full text : https://www.nature.com/articles/nature22056
Find more like this one (cited by): https://scholar.google.com/scholar?cites=8636865727048901331&as_sdt=1000005&sciodt=0,16&hl=en
Type: Journal Article
Serial number: 1789